Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.565 EUR | -1.57% | -1.26% | -4.85% |
06/06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
05/06 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
- Stock Market
- Equities
- IMAB Stock
- 0VY Stock
- News I-Mab
- Transcripts